Iron deficiency and iron chelators are known to alter folate metabolism in mammals, but the underlying biochemical mechanisms have not been established. Although many studies have demonstrated that the iron chelators mimosine and deferoxamine inhibit DNA replication in mammalian cells, their mechanism of action remains controversial. The effects of mimosine on folate metabolism were investigated in human MCF-7 cells and SH-SY5Y neuroblastoma. Our findings indicate that mimosine is a folate antagonist and that its effects are cell-specific. MCF-7 cells cultured in the presence of 350 M mimosine were growth-arrested, whereas mimosine had no effect on SH-SY5Y cell proliferation. Mimosine altered the distribution of folate cofactor forms in MCF-7 cells, indicating that mimosine targets folate metabolism. However, mimosine does not influence folate metabolism in SH-SY5Y neuroblastoma. The effect of mimosine on folate metabolism is associated with decreased cytoplasmic serine hydroxymethyltransferase (cSHMT) expression in MCF-7 cells but not in SH-SY5Y cells. MCF-7 cells exposed to mimosine for 24 h have a 95% reduction in cSHMT protein, and cSHMT promoter activity is reduced over 95%. Transcription of the cSHMT gene is also inhibited by deferoxamine in MCF-7 cells, indicating that mimosine inhibits cSHMT transcription by chelating iron. Analyses of mimosine-resistant MCF-7 cell lines demonstrate that although the effect of mimosine on cell cycle is independent of its effects on cSHMT expression, it inhibits both processes through a common regulatory mechanism.There are several well characterized cellular responses that are triggered following decreases in the regulatory, non-ferritin-bound iron pool. Many of these responses are mediated through the iron regulatory protein, which can bind with specificity to certain mRNA species and regulate translation (1). The concentration of cellular regulatory iron is decreased by iron deficiency or by elevated expression of heavy chain ferritin, a protein that sequesters intracellular iron (2, 3). Sequestration of intracellular iron by chelators, including DFO, 1 has been commonly used to trigger physiological changes associated with iron deficiency. The influence of iron deficiencies, both induced and naturally occurring, on folate metabolism has been well documented in cell culture models, animal models, and humans. Iron deficiency can result in morphological alterations in granulocytes similar to folate deficiency (4), and iron deficiency has been demonstrated to impair folate utilization in some but not all tissues (5). In addition, maternal iron deficiency decreases secretion of folate into milk (6, 7) without decreasing maternal serum or red blood cell folate levels in rats. However, the biochemical mechanisms underlying the influence of iron deficiency on folate metabolism have not been established (6).Mimosine, a plant amino acid and tyrosine analog ( Fig. 1), is a toxin that chelates iron and inhibits mammalian DNA replication. Mimosine is known to block DNA replication...